ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,018.39
      -0.34%
      US Tech 100
      16,938.80
      -0.26%
      Dow Jones
      37,903.29
      0.23%
      Brent Oil
      83.54
      -2.74%
      Bitcoin
      58,266.23
      -3.85%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Adamas Pharmaceuticals Inc (ADMS)

      7. Adamas Pharmaceuticals Inc (ADMS) News

      ADMS

      Adamas Pharmaceuticals (ADMS)

      Adamas Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ADMS
      DateTimeSourceHeadlineSymbolCompany
      02/15/20226:35AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/26/202211:01AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      12/10/20218:53AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      12/02/20216:15AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/20214:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/20214:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/20214:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/20214:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/20214:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/202111:54AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/202111:47AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/202111:46AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/202111:43AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/20219:28AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/20219:18AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/20219:17AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/20219:12AMGlobeNewswire Inc.Supernus Pharmaceuticals Completes Acquisition of Adamas PharmaceuticalsNASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/23/20218:22AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/23/20218:00AMGlobeNewswire Inc.Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender OfferNASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/23/20216:05AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/18/20218:58AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/10/20214:03PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/01/20214:55PMEdgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/25/20215:24PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/25/202111:26AMEdgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/25/202110:22AMEdgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/19/20214:27PMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/13/20215:14PMEdgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/12/20217:56AMEdgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/12/20217:05AMEdgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:ADMSAdamas Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ADMS